IL-10, an anti-inflammatory cytokine, creates an immunosuppressive environment in non-small cell lung cancer (NSCLC), inducing resistance to apoptosis, angiogenesis, tumor growth and metastasis [55–57]. The gene discussed is IL10; the disease is neoplasm.